Eugene
Clinical trials for coronavirus vaccines continue and volunteers are still needed
Medford, OR – According to the statement, Velocity Clinical Research in Medford is currently recruiting up to 400 people to take part in coronavirus vaccine studies.
Note that Velocity Clinical Research owns 14 clinical trials sites in 10 states across the US.
And the Velocity Clinical Research in Medford is actively enrolling patients in three adult and two adolescent studies.
According to the statement, it’s estimated that 100,000 volunteers are needed across all active studies in the US in order to create a more effective COVID vaccine solution for the entire US population.
So, ladies and gentlemen, if you are interested in volunteering for a COVID vaccine study can register here. Thank you for your time.
-
Oregon1 week agoGov. Kotek calls out Trump administration over “unworkable” federal rollout, says “eligible people could lose health care due to paperwork problems and system failures”
-
Oregon6 days agoGov. Kotek reacts to immigration debate, says “Trump’s chaos threatened Oregon” and claims she “took action to protect immigrant and refugee families”
-
Oregon1 week agoGov. Kotek accuses ICE of repeatedly engaging in “illegitimate activities” and spreading fear after directing Oregon DMV to stop issuing undercover license plates
-
Oregon3 days agoOregon Sen. Jeff Merkley reacts to new Trump admin rule he says could “make it harder for critical workers to get graduate degrees”
-
Eugene6 days agoEugene Police respond to motorcycle crash on Beltline Highway on-ramp, rider hospitalized with non-life-threatening injuries
-
Eugene1 week agoSkinner Butte summit road and parking lot to remain closed until October due to wildfire concerns
-
Eugene1 week agoMotorcyclist hospitalized after crashing into guardrail near Beltline Highway and Delta Highway ramp, speed believed to be factor
-
Oregon3 days agoSen. Merkley states “American people deserve to know the true cost of Trump’s war with Iran” as lawmakers push independent review amid growing concerns over spending estimates
